InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Malin Life Sciences Holdings Ltd. Director active across 1 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 10 reports have been logged. Total volume traded: €877k. The latest transaction was filed on 6 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
€11,1571,828 shares@ €6.10362.5% of flow
COMMON STOCK
SEC:0001104659-21-146952·
Ideal exit: 2 Sept 2022 (T+270)
€11,1571,828 shares@ €6.10361.3% of flow
COMMON STOCK
SEC:0001104659-21-146952:0·
Ideal exit: 2 Sept 2022 (T+270)
€173,40928,592 shares@ €6.064939.6% of flow
COMMON STOCK
SEC:0001104659-21-146000·
Ideal exit: 27 Aug 2022 (T+270)
€173,40928,592 shares@ €6.064919.8% of flow
COMMON STOCK
SEC:0001104659-21-146000:0·
Ideal exit: 27 Aug 2022 (T+270)
€6,4561,054 shares@ €6.12561.5% of flow
COMMON STOCK
SEC:0001104659-21-144590·
Ideal exit: 21 Aug 2022 (T+270)
€6,4561,054 shares@ €6.12560.7% of flow
COMMON STOCK
SEC:0001104659-21-144590:0·
Ideal exit: 21 Aug 2022 (T+270)
€72,70211,104 shares@ €6.547416.6% of flow
COMMON STOCK
SEC:0001104659-21-143142·
Ideal exit: 16 Aug 2022 (T+270)
€72,70211,104 shares@ €6.54748.3% of flow
COMMON STOCK
SEC:0001104659-21-143142:0·
Ideal exit: 16 Aug 2022 (T+270)
€174,53327,680 shares@ €6.305439.8% of flow
COMMON STOCK
SEC:0001104659-21-141457·
Ideal exit: 13 Aug 2022 (T+270)
€174,53327,680 shares@ €6.305419.9% of flow
COMMON STOCK
SEC:0001104659-21-141457:0·
Ideal exit: 13 Aug 2022 (T+270)
10 of 10 declarations
About Malin Life Sciences Holdings Ltd
Malin Life Sciences Holdings Ltd is a director at Poseida Therapeutics, Inc.
